🔗 Share this article

Texas Attorney General Paxton is suing the manufacturers of acetaminophen, asserting the companies concealed safety concerns that the medication posed to pediatric brain development.

The lawsuit follows a month after President Donald Trump publicized an unproven link between consuming acetaminophen - also known as acetaminophen - throughout gestation and autism in young ones.

The attorney general is taking legal action against the pharmaceutical giant, which once produced the medication, the only pain reliever suggested for pregnant women, and Kenvue, which currently produces it.

In a statement, he stated they "misled consumers by profiting off of suffering and promoting medication regardless of the dangers."

The manufacturer asserts there is lacking scientific proof tying Tylenol to autism spectrum disorder.

"These companies lied for decades, knowingly endangering millions to boost earnings," the attorney general, a Republican, stated.

The company said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the security of acetaminophen and the potential impact that could have on the health of women and children in America."

On its official site, Kenvue also stated it had "consistently assessed the pertinent research and there is insufficient valid information that shows a proven link between using acetaminophen and autism."

Organizations speaking for physicians and health professionals concur.

The American College of Obstetricians and Gynecologists has stated paracetamol - the key substance in Tylenol - is among limited choices for pregnant women to address discomfort and fever, which can pose significant medical dangers if left untreated.

"In more than two decades of studies on the consumption of paracetamol in pregnancy, zero credible investigations has successfully concluded that the consumption of paracetamol in any period of pregnancy leads to brain development issues in young ones," the organization said.

The court filing references recent announcements from the former administration in arguing the medication is potentially dangerous.

In recent weeks, Trump caused concern from public health officials when he told women during pregnancy to "struggle intensely" not to consume Tylenol when ill.

The FDA then published an announcement that medical professionals should think about restricting the usage of Tylenol, while also mentioning that "a proven link" between the drug and autism in young ones has remains unverified.

The Health Department head Kennedy, who manages the FDA, had vowed in April to conduct "a massive testing and research effort" that would establish the source of autism spectrum disorder in a limited time.

But experts advised that discovering a sole reason of autism spectrum disorder - considered by experts to be the outcome of a complex mix of inherited and external influences - would be difficult.

Autism is a category of permanent neurological difference and impairment that affects how people experience and relate to the environment, and is diagnosed using physician assessments.

In his lawsuit, the attorney general - a Trump ally who is seeking federal office - alleges Kenvue and J&J "deliberately disregarded and sought to suppress the science" around acetaminophen and autism spectrum disorder.

This legal action aims to force the firms "destroy any promotional materials" that states acetaminophen is reliable for women during pregnancy.

The court case echoes the grievances of a assembly of mothers and fathers of children with autism and ADHD who sued the manufacturers of acetaminophen in recently.

The court threw out the lawsuit, declaring studies from the family's specialists was inconclusive.